Analysis of 20 years of data highlights differences in reimbursement trends across ophthalmology subspecialties and practice ...
Health chiefs have been forced to apologise to a 93-year-old grandmother after they took nearly eight months to respond to ...
Sanofi may rebid for Ocular Therapeutix, Inc. to boost retinal therapeutics ahead of Dupixent patent expiry. Click for more ...
A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition ...
A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition ...
In a preliminary report of its 2025 results, Apellis said that sales of its geographic atrophy (GA) drug Syfovre came in at ...
A data monitoring committee recommended stopping the phase 3 trials of efgartigimod in thyroid eye disease due to lack of ...
A woman who lost her vision due to a rare condition before having her sight restored with injections that pumped up her eye has described the treatment as “phenomenal”.
The treatment with what is thought of as a common medical supply has shown positive results in the patients who have received ...
Moorfields hospital in London is the world's first dedicated clinic for the disorder and seven out of eight patients given ...
People with a rare and untreatable condition that causes blindness have had their sight restored with injections of a ...